Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals
NCT06252428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2024-03-05
Summary
This descriptive cross-sectional study will beconducted in Suez Canal University Hospitals (SCUHs) in Ismailia, Egypt. The study aims to detect Escherichia coli biofilm producers to improve prognosis and treatment and reduce morbidity and mortality rates due to this infection.
Conditions
- Escherichia Coli Infections
Sponsors & Collaborators
-
Suez Canal University
lead OTHER
Principal Investigators
-
Rania Kishk, professor · Faculty of Medicine - Suez Canal University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-20
- Primary Completion
- 2024-02-01
- Completion
- 2024-02-20
Countries
- Egypt
Study Locations
More Related Trials
-
Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital
NCT07255443 ·Status: NOT_YET_RECRUITING
-
Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 ·Status: UNKNOWN ·Phase: NA
-
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625 ·Status: UNKNOWN
-
Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU
NCT05833282 ·Status: UNKNOWN
-
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
NCT00573235 ·Status: COMPLETED
-
Surveillance Study of Candiduria in Hospitalized Patients
NCT03910764 ·Status: COMPLETED
-
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 ·Status: COMPLETED
-
Study of Antibiotic Utilization Measures and Control of ESBLs in China
NCT00488813 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 ·Status: COMPLETED
-
ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
NCT07172932 ·Status: COMPLETED
-
Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards
NCT02456818 ·Status: UNKNOWN
-
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
NCT04161053 ·Status: RECRUITING ·Phase: PHASE3
-
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
NCT00573521 ·Status: COMPLETED
-
A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli
NCT00724919 ·Status: COMPLETED
-
Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 ·Status: RECRUITING
-
Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.
NCT03248999 ·Status: COMPLETED ·Phase: NA
-
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
NCT03967301 ·Status: UNKNOWN ·Phase: NA
-
Community-associated Highly-Resistant Enterobacterales
NCT03924934 ·Status: COMPLETED
-
International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
NCT06634940 ·Status: RECRUITING
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
NCT01345929 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 ·Status: COMPLETED
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
NCT06576258 ·Status: RECRUITING ·Phase: NA
-
Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study
NCT05521139 ·Status: COMPLETED